封面
市场调查报告书
商品编码
1433570

造影超音波市场市场规模、份额、趋势分析报告:按产品类型、最终用途、地区和细分市场预测,2024-2030 年

Contrast Enhanced Ultrasound Market Size, Share & Trends Analysis Report By Product, By Type, By End-use, By Region, And Segment Forecasts, 2024 - 2030

出版日期: | 出版商: Grand View Research | 英文 130 Pages | 商品交期: 2-10个工作天内

价格

造影超音波市场成长与趋势:

预计到 2030 年,全球造影超音波市场将达到 29.9 亿美元。

根据Grand View Research, Inc.的最新报告,预计2024年至2030年复合年增长率为5.70%。心血管疾病、癌症和肝臟疾病等慢性病盛行率的上升、老年人口的增加以及超音波成像技术的不断进步预计将推动预测期内超音波造影的成长,这是主要因素。与 CT 和 MRI 等其他造影方式相比,对比超音波的使用进一步推动了市场成长,因为其成本较低、便携且无电离辐射。

心血管疾病盛行率的上升推动了市场的成长。根据世界卫生组织 (WHO) 统计,心血管疾病每年导致约 1,790 万人死亡,成为全球第一大死因。 2022年,被诊断出患有心血管疾病的人数预计将增加。因此,造影超音波(CEUS)在这些疾病的检测和监测中发挥重要作用。 CEUS 使用造影显影剂增强超音波影像,以更清晰地显示心臟和血管。可用于诊断心臟瓣膜疾病、主动脉瘤、周边动脉疾病等。

此外,CEUS是一种非侵入性且安全的成像方法,不使用电离辐射。这使其成为优于使用电离辐射的 CT 和 MRI 等其他显像模式的首选。 2021年,发表在《美国心臟病学会杂誌》上的一项研究表明,与其他显像模式相比,CEUS在检测冠状动脉疾病方面具有更高的诊断准确性。 CEUS以其许多优点,正成为心血管疾病诊断和治疗中越来越重要的工具。

造影超音波市场报告亮点:

  • 按产品划分,2023年设备部门占收益占有率最大。这是由于与 CEUS 相容的超音波成像技术拥有最大的装置量。
  • 由于 FDA核准其用于肝臟和儿童成像,预计显影剂年增长率快速增长。
  • 按类型划分,非标靶细分市场在 2023 年占据了最大的收益占有率,因为大多数市售显影剂都是非标靶的。
  • 由于腹痛、腹部/胸部创伤和心臟併发症等医疗状况导致的紧急就诊数量增加,医院细分市场在 2023 年占据了最大的市场占有率。
  • 随着初级和二级护理医生透过使用超音波检查设备实现经济和患者照护效益,预计诊所部门在预测期内将实现良好的复合年增长率。
  • 在亚太地区,由于 CT 和 MRI 等先进 CT/MRI显像模式的获取有限,以及中国和印度心血管疾病负担的增加,该市场预计将以最快的复合年增长率增长。

目录

第一章调查方法与范围

第 2 章执行摘要

第 3 章造影超音波市场变数、趋势、范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 造影超音波市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第 4 章造影超音波市场:按产品估计和趋势分析

  • 按产品分類的市场占有率(2023/2030)
  • 细分仪表板
  • 按产品分類的全球造影超音波市场前景
  • 市场规模、预测与趋势分析(2018-2030)

第五章造影超音波市场:按类型估计和趋势分析

  • 按类型分類的市场占有率(2023/2030)
  • 细分仪表板
  • 按类型分類的全球造影超音波市场展望
  • 市场规模、预测与趋势分析(2018-2030)

第六章造影超音波市场:依最终用途分类的估计与趋势分析

  • 依最终用途分類的市场占有率(2023/2030)
  • 细分仪表板
  • 按最终用途分類的全球造影超音波市场前景
  • 市场规模、预测与趋势分析(2018-2030)

第七章造影超音波市场:按地区估计和趋势分析

  • 按地区分類的市场占有率分析(2023/2030)
  • 按地区分類的市场仪表板
  • 按地区市场概述
  • 市场规模、预测与趋势分析(2018-2030)
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
  • 中东/非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章 竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争对手分类
  • 供应商形势
    • List of key distributors and channel partners
    • Key customers
    • Key company market share analysis, 2023
    • Lantheus Medical Imaging, Inc.
    • GE Healthcare
    • Bracco Diagnostic
    • GE HealthCare
    • Siemens Healthcare GmbH
    • Koninklijke Philips NV
    • CANON MEDICAL SYSTEMS CORPORATION
    • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
Product Code: GVR-4-68039-141-1

Contrast Enhanced Ultrasound Market Growth & Trends:

The global contrast enhanced ultrasound market is anticipated to reach USD 2.99 billion by 2030. It is projected to grow at a CAGR of 5.70% from 2024 - 2030, according to a new report by Grand View Research, Inc. The rising prevalence of chronic disorders such as cardiovascular ailments, cancer, and liver disease, growing geriatric population, and increasing technological advancements in the ultrasound imaging technology are the major factors anticipated to boost the contrast-enhanced ultrasound market growth over the forecast period. Growth in the market is further propelled using contrast-enhanced ultrasound over other imaging modalities like CT and MRI has become more popular due to its lower cost, portability, and lack of ionizing radiation.

The rising prevalence of cardiovascular diseases fueling the market growth. According to the World Health Organization (WHO), an estimated 17.9 million deaths occur each year due to cardiovascular diseases, making it the leading cause of death globally. In 2022, it is expected that there will be an increase in the number of people diagnosed with cardiovascular diseases. This is where contrast-enhanced ultrasound (CEUS) can play a crucial role in helping to detect and monitor these conditions. CEUS uses a contrast agent that enhances the ultrasound image, allowing for better visualization of the heart and blood vessels. It can be used to diagnose conditions such as heart valve disease, aortic aneurysm, and peripheral artery disease.

Furthermore, CEUS is a non-invasive and safe imaging modality that does not use ionizing radiation. This makes it a preferred option over other imaging modalities like CT and MRI, which use ionizing radiation. In 2021, a study published in the Journal of the American College of Cardiology showed that CEUS had high diagnostic accuracy in detecting coronary artery disease compared to other imaging modalities. With its many benefits, CEUS is becoming an increasingly important tool in diagnosing and managing cardiovascular diseases.

Contrast Enhanced Ultrasound Market Report Highlights:

  • Based on product, the equipment segment held the largest revenue share in 2023. This can be attributed to the largest installed base of ultrasound imaging technology compatible with CEUS.
  • The contrast agents segment is expected to grow at the fastest CAGR of 6.32% during the forecast period owing to its approval of usage in the liver and pediatric imaging by the FDA.
  • Based on type, the non-targeted segment held the largest revenue share in 2023 as most of the commercially available contrast agents are non-targeted in nature.
  • The hospitals segment held the largest market share in 2023 owing to the increasing number of emergency visits with medical conditions such as abdominal pain, abdominal/thoracic trauma, and cardiac complications
  • The clinics segment is anticipated to witness lucrative CAGR over the forecast period owing to the realization of economic and patient care benefits with the adoption of sonography devices in practice among physicians at primary and secondary care
  • In Asia Pacific, the market is expected to grow at the fastest CAGR owing to the limited accessibility to advanced CT/MRI imaging modalities such as CT and MRI, and the growing burden of cardiovascular disorders in China and India.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Type
    • 1.2.3. End-use
    • 1.2.4. Regional scope
    • 1.2.5. Estimates and forecasts timeline
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased database
    • 1.4.2. GVR's internal database
    • 1.4.3. Secondary sources
    • 1.4.4. Primary research
    • 1.4.5. Details of primary research
      • 1.4.5.1. Data for primary interviews in North America
      • 1.4.5.2. Data for primary interviews in Europe
      • 1.4.5.3. Data for primary interviews in Asia Pacific
      • 1.4.5.4. Data for primary interviews in Latin America
      • 1.4.5.5. Data for Primary interviews in MEA
  • 1.5. Information or Data Analysis
    • 1.5.1. Data analysis models
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
    • 1.7.2. Approach 1: Commodity flow approach
    • 1.7.3. Volume price analysis (Model 2)
    • 1.7.4. Approach 2: Volume price analysis
  • 1.8. List of Secondary Sources
  • 1.9. List of Primary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product outlook
    • 2.2.2. Type outlook
    • 2.2.3. End-use
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Contrast Enhanced Ultrasound Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market driver analysis
      • 3.2.1.1. Increasing prevalence of chronic disorders
      • 3.2.1.2. Technological advancements
      • 3.2.1.3. Extension of indications for use
    • 3.2.2. Market restraint analysis
      • 3.2.2.1. Low stability of the contrast agents
      • 3.2.2.2. Procedural complexity
      • 3.2.2.3. Availability of alternatives
  • 3.3. Contrast Enhanced Ultrasound Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic landscape
      • 3.3.2.3. Social landscape
      • 3.3.2.4. Technological landscape
      • 3.3.2.5. Environmental landscape
      • 3.3.2.6. Legal landscape

Chapter 4. Contrast Enhanced Ultrasound Market: Product Estimates & Trend Analysis

  • 4.1. Product Market Share, 2023 & 2030
  • 4.2. Segment Dashboard
  • 4.3. Global Contrast Enhanced Ultrasound Market by Product Outlook
  • 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.4.1. Equipment
      • 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 4.4.2. Contrast Agents
      • 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Contrast Enhanced Ultrasound Market: Type Estimates & Trend Analysis

  • 5.1. Type Market Share, 2023 & 2030
  • 5.2. Segment Dashboard
  • 5.3. Global Contrast Enhanced Ultrasound Market by Type Outlook
  • 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.4.1. Non-targeted
      • 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 5.4.2. Targeted
      • 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Contrast Enhanced Ultrasound Market: End-use Estimates & Trend Analysis

  • 6.1. End-use Market Share, 2023 & 2030
  • 6.2. Segment Dashboard
  • 6.3. Global Contrast Enhanced Ultrasound Market by End-use Outlook
  • 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.4.1. Hospitals
      • 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.2. Clinics
      • 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
    • 6.4.3. Ambulatory Diagnostic Centers
      • 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Contrast Enhanced Ultrasound Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2023 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Regulatory framework/reimbursement structure
      • 7.5.1.3. Competitive scenario
      • 7.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Regulatory framework/reimbursement structure
      • 7.5.2.3. Competitive scenario
      • 7.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Regulatory framework/reimbursement structure
      • 7.6.1.3. Competitive scenario
      • 7.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Regulatory framework/reimbursement structure
      • 7.6.2.3. Competitive scenario
      • 7.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Regulatory framework/reimbursement structure
      • 7.6.3.3. Competitive scenario
      • 7.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Regulatory framework/reimbursement structure
      • 7.6.4.3. Competitive scenario
      • 7.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Regulatory framework/reimbursement structure
      • 7.6.5.3. Competitive scenario
      • 7.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Regulatory framework/reimbursement structure
      • 7.6.6.3. Competitive scenario
      • 7.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Regulatory framework/reimbursement structure
      • 7.6.7.3. Competitive scenario
      • 7.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Regulatory framework/reimbursement structure
      • 7.6.8.3. Competitive scenario
      • 7.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Regulatory framework/reimbursement structure
      • 7.7.1.3. Competitive scenario
      • 7.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Regulatory framework/reimbursement structure
      • 7.7.2.3. Competitive scenario
      • 7.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Regulatory framework/reimbursement structure
      • 7.7.3.3. Competitive scenario
      • 7.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Regulatory framework/reimbursement structure
      • 7.7.4.3. Competitive scenario
      • 7.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Regulatory framework/reimbursement structure
      • 7.7.5.3. Competitive scenario
      • 7.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Regulatory framework/reimbursement structure
      • 7.7.6.3. Competitive scenario
      • 7.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Regulatory framework/reimbursement structure
      • 7.8.1.3. Competitive scenario
      • 7.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.2. Mexico
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Regulatory framework/reimbursement structure
      • 7.8.2.3. Competitive scenario
      • 7.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.8.3. Argentina
      • 7.8.3.1. Key country dynamics
      • 7.8.3.2. Regulatory framework/reimbursement structure
      • 7.8.3.3. Competitive scenario
      • 7.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Regulatory framework/reimbursement structure
      • 7.9.1.3. Competitive scenario
      • 7.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Regulatory framework/reimbursement structure
      • 7.9.2.3. Competitive scenario
      • 7.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Regulatory framework/reimbursement structure
      • 7.9.3.3. Competitive scenario
      • 7.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Regulatory framework/reimbursement structure
      • 7.9.4.3. Competitive scenario
      • 7.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2023
    • 8.3.4. Lantheus Medical Imaging, Inc.
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. GE Healthcare
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Bracco Diagnostic
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. GE HealthCare
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Siemens Healthcare GmbH
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Koninklijke Philips N.V.
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. CANON MEDICAL SYSTEMS CORPORATION
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives

List of Tables

  • Table 1 List of abbreviation
  • Table 2 North America contrast enhanced ultrasound market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 4 North America contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 5 North America contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 6 U.S. contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 7 U.S. contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 8 U.S. contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 9 Canada contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 10 Canada contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 11 Canada contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 12 Europe contrast enhanced ultrasound market, by region, 2018 - 2030 (USD Million)
  • Table 13 Europe contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 14 Europe contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 15 Europe contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 16 Germany contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 17 Germany contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 18 Germany contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 19 UK contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 20 UK contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 21 UK contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 22 France contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 23 France contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 24 France contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 25 Italy contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 26 Italy contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 27 Italy contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 28 Spain contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 29 Spain contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 30 Spain contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 31 Denmark contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 32 Denmark contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 33 Denmark contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 34 Sweden contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 35 Sweden contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 36 Sweden contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 37 Norway contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 38 Norway contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 39 Norway contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific contrast enhanced ultrasound market, by region, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 44 China contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 45 China contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 46 China contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 47 Japan contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 48 Japan contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 49 Japan contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 50 India contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 51 India contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 52 India contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 53 South Korea contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 54 South Korea contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 55 South Korea contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 56 Australia contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 57 Australia contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 58 Australia contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 59 Thailand contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 60 Thailand contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 61 Thailand contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 62 Latin America contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 63 Latin America contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 64 Latin America Non-targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 65 Latin America market, by end-use, 2018 - 2030 (USD Million)
  • Table 66 Latin America Targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 67 Latin America contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 68 Brazil contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 69 Brazil contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 70 Brazil Non-targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 71 Brazil market, by end-use, 2018 - 2030 (USD Million)
  • Table 72 Brazil Targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 73 Brazil contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 74 Mexico contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 75 Mexico contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 76 Mexico Non-targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 77 Mexico market, by end-use, 2018 - 2030 (USD Million)
  • Table 78 Mexico Targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 79 Mexico contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 80 Argentina contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 81 Argentina contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 82 Argentina Non-targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 83 Argentina market, by end-use, 2018 - 2030 (USD Million)
  • Table 84 Argentina Targeted market, by end-use, 2018 - 2030 (USD Million)
  • Table 85 Argentina contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 86 MEA contrast enhanced ultrasound market, by region, 2018 - 2030 (USD Million)
  • Table 87 MEA contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 88 MEA contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 89 MEA contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 90 South Africa contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 91 South Africa contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 92 South Africa contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 93 Saudi Arabia contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 94 Saudi Arabia contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 95 Saudi Arabia contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 96 UAE contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 97 UAE contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 98 UAE contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)
  • Table 99 Kuwait contrast enhanced ultrasound market, by product, 2018 - 2030 (USD Million)
  • Table 100 Kuwait contrast enhanced ultrasound market, by type, 2018 - 2030 (USD Million)
  • Table 101 Kuwait contrast enhanced ultrasound market, by end-use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Contrast enhanced ultrasound market: market outlook
  • Fig. 14 Contrast enhanced ultrasound market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Contrast enhanced ultrasound market driver impact
  • Fig. 20 Contrast enhanced ultrasound market restraint impact
  • Fig. 21 Contrast enhanced ultrasound market strategic initiatives analysis
  • Fig. 22 Contrast enhanced ultrasound market: Product movement analysis
  • Fig. 23 Contrast enhanced ultrasound market: Product outlook and key takeaways
  • Fig. 24 Equipment market estimates and forecast, 2018 - 2030
  • Fig. 25 Contrast agents estimates and forecast, 2018 - 2030
  • Fig. 26 Contrast enhanced ultrasound market: Type movement Analysis
  • Fig. 27 Contrast enhanced ultrasound market: Type outlook and key takeaways
  • Fig. 28 Non-targeted market estimates and forecasts, 2018 - 2030
  • Fig. 29 Targeted market estimates and forecasts,2018 - 2030
  • Fig. 30 Contrast enhanced ultrasound market: end-use movement analysis
  • Fig. 31 Contrast enhanced ultrasound market: end-use outlook and key takeaways
  • Fig. 32 Hospitals market estimates and forecasts, 2018 - 2030
  • Fig. 33 Clinics market estimates and forecasts,2018 - 2030
  • Fig. 34 Ambulatory diagnostic centers market estimates and forecasts, 2018 - 2030
  • Fig. 35 Global contrast enhanced ultrasound market: Regional movement analysis
  • Fig. 36 Global contrast enhanced ultrasound market: Regional outlook and key takeaways
  • Fig. 37 Global contrast enhanced ultrasound market share and leading players
  • Fig. 38 North America market share and leading players
  • Fig. 39 Europe market share and leading players
  • Fig. 40 Asia Pacific market share and leading players
  • Fig. 41 Latin America market share and leading players
  • Fig. 42 Middle East & Africa market share and leading players
  • Fig. 43 North America: SWOT
  • Fig. 44 Europe SWOT
  • Fig. 45 Asia Pacific SWOT
  • Fig. 46 Latin America SWOT
  • Fig. 47 MEA SWOT
  • Fig. 48 North America
  • Fig. 49 North America market estimates and forecasts, 2018 - 2030
  • Fig. 50 U.S.
  • Fig. 51 U.S. market estimates and forecasts, 2018 - 2030
  • Fig. 52 Canada
  • Fig. 53 Canada market estimates and forecasts, 2018 - 2030
  • Fig. 54 Europe
  • Fig. 55 Europe market estimates and forecasts, 2018 - 2030
  • Fig. 56 UK
  • Fig. 57 UK market estimates and forecasts, 2018 - 2030
  • Fig. 58 Germany
  • Fig. 59 Germany market estimates and forecasts, 2018 - 2030
  • Fig. 60 France
  • Fig. 61 France market estimates and forecasts, 2018 - 2030
  • Fig. 62 Italy
  • Fig. 63 Italy market estimates and forecasts, 2018 - 2030
  • Fig. 64 Spain
  • Fig. 65 Spain market estimates and forecasts, 2018 - 2030
  • Fig. 66 Denmark
  • Fig. 67 Denmark market estimates and forecasts, 2018 - 2030
  • Fig. 68 Sweden
  • Fig. 69 Sweden market estimates and forecasts, 2018 - 2030
  • Fig. 70 Norway
  • Fig. 71 Norway market estimates and forecasts, 2018 - 2030
  • Fig. 72 Asia Pacific
  • Fig. 73 Asia Pacific market estimates and forecasts, 2018 - 2030
  • Fig. 74 China
  • Fig. 75 China market estimates and forecasts, 2018 - 2030
  • Fig. 76 Japan
  • Fig. 77 Japan market estimates and forecasts, 2018 - 2030
  • Fig. 78 India
  • Fig. 79 India market estimates and forecasts, 2018 - 2030
  • Fig. 80 Thailand
  • Fig. 81 Thailand market estimates and forecasts, 2018 - 2030
  • Fig. 82 South Korea
  • Fig. 83 South Korea market estimates and forecasts, 2018 - 2030
  • Fig. 84 Australia
  • Fig. 85 Australia market estimates and forecasts, 2018 - 2030
  • Fig. 86 Latin America
  • Fig. 87 Latin America market estimates and forecasts, 2018 - 2030
  • Fig. 88 Brazil
  • Fig. 89 Brazil market estimates and forecasts, 2018 - 2030
  • Fig. 90 Mexico
  • Fig. 91 Mexico market estimates and forecasts, 2018 - 2030
  • Fig. 92 Argentina
  • Fig. 93 Argentina market estimates and forecasts, 2018 - 2030
  • Fig. 94 Middle East and Africa
  • Fig. 95 Middle East and Africa market estimates and forecasts, 2018 - 2030
  • Fig. 96 South Africa
  • Fig. 97 South Africa market estimates and forecasts, 2018 - 2030
  • Fig. 98 Saudi Arabia
  • Fig. 99 Saudi Arabia market estimates and forecasts, 2018 - 2030
  • Fig. 100 UAE
  • Fig. 101 UAE market estimates and forecasts, 2018 - 2030
  • Fig. 102 Kuwait
  • Fig. 103 Kuwait market estimates and forecasts, 2018 - 2030
  • Fig. 104 Market share of key market players- Contrast enhanced ultrasound market